Possible long-term consequences for patients with diabetes forced to switch to alternative medications during the semaglutide shortage include the risk of losing ground in glycemic control, having uncontrolled diabetes with associated symptoms, and other adverse events.
Related Keywords
Ian Neeland , University Hospitals Harrington Heart Vascular Institute , Case Western Reserve University School Of Medicine , Novel Approaches , Vascular Metabolic Disease , University Hospitals Harrington Heart , Vascular Institute , Case Western Reserve University School , Semaglutide , Diabetes , Glycemic Control ,
comparemela.com © 2020. All Rights Reserved.